Cite Filings / AEON / 0001104659-23-083191
Feed Companies Filings Check
Sign in
8-K

Current Report

AEON Biopharma, Inc. · Filed 2023-07-24 · Acc 0001104659-23-083191

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , tm2321874d1_8k.htm

Around this filing

  • 2023-07-27 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Regulation FD disclosure · Other events
  • 2023-07-24 3 Initial Statement of Ownership
  • 2023-07-24 3 Initial Statement of Ownership
  • 2023-07-24 3 Initial Statement of Ownership
  • 2023-07-24 3 Initial Statement of Ownership
  • 2023-07-24 8-K Regulation FD disclosure
  • 2023-07-17 8-K Delisting notice · Regulation FD disclosure

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading tm2321874d1_8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…